Clinical Trial Update: Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing three regimens in relapsed or refractory acute myeloid leukemia (AML).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED